GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Cash And Cash Equivalents

IQMDU (Intelligent Medicine Acquisition) Cash And Cash Equivalents : $0.05 Mil (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Cash And Cash Equivalents?

Intelligent Medicine Acquisition's quarterly cash and cash equivalents declined from Jun. 2022 ($0.26 Mil) to Sep. 2022 ($0.16 Mil) but then stayed the same from Sep. 2022 ($0.16 Mil) to Dec. 2022 ($0.05 Mil).

Intelligent Medicine Acquisition's annual cash and cash equivalents increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.59 Mil) but then declined from Dec. 2021 ($0.59 Mil) to Dec. 2022 ($0.05 Mil).

Intelligent Medicine Acquisition Cash And Cash Equivalents Historical Data

The historical data trend for Intelligent Medicine Acquisition's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Cash And Cash Equivalents Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
Cash And Cash Equivalents
0.59 0.05

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
Cash And Cash Equivalents Get a 7-Day Free Trial 0.07 0.59 0.26 0.16 0.05

Intelligent Medicine Acquisition Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Intelligent Medicine Acquisition  (NAS:IQMDU) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Intelligent Medicine Acquisition Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Medicine Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Cash And Cash Equivalents
Comparable Companies
IFIN WAVC FRW SHCA AVAC OCA ISLE BIOT DWIN TRCA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Website
https://iqmdspac.com
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817